Quest Diagnostics
DGX
#1030
Rank
$16.38 B
Marketcap
$140.55
Share price
-0.01%
Change (1 day)
-5.17%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2022 (TTM): $1.93 B

According to Quest Diagnostics 's latest financial reports the company's current earnings (TTM) are $1.93 B. In 2021 the company made an earning of $2.59 B an increase over its 2020 earnings that were of $1.88 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$1.93 B-25.7%
2021$2.59 B37.95%
2020$1.88 B75.09%
2019$1.07 B16.2%
2018$0.92 B-10.1%
2017$1.03 B-5.16%
2016$1.08 B-2.78%
2015$1.11 B31.57%
2014$0.84 B-37.02%
2013$1.34 B26.17%
2012$1.06 B24.78%
2011$0.85 B-27.7%
2010$1.18 B-3.55%
2009$1.22 B20.51%
2008$1.01 B11.68%
2007$0.91 B-7.31%
2006$0.98 B8.11%
2005$0.91 B9.02%
2004$0.83 B13.19%
2003$0.73 B36.03%
2002$0.54 B63.07%
2001$0.33 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$2.74 B 41.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.68 M-97.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.43 M-100.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.16 B-108.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.68 B-64.68%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-$6.56 M-100.34%๐Ÿ‡บ๐Ÿ‡ธ USA